Skip to main content
. 2014 Oct 1;27(8):392–397. doi: 10.1089/vim.2014.0025

Table 2.

Prevalence of Transmitted Drug Resistance Among 536 Antiretroviral-Naive MSM HIV Patients, Including 266 Acute and 270 Chronic HIV-1 Infected Patients in You'an Hospital, Beijing, China

  Total (536) AHI/EHI (266) CHI (270)  
  n % [95% CI] n % [95% CI] n % [95% CI] p-Value
Any class 42 7.8 [5.7–10.5] 22 8.3 [5.2–12.3] 20 7.4 [4.6–11.2] 0.710
NRTI 5 0.9 [0.3–2.2] 3 1.1 [0.2–3.3] 2 0.7 [0.1–2.7] 0.641
NNRTI 9 1.7 [0.8–3.3] 5 1.9 [0.6–4.4] 4 1.5 [0.4–3.8] 0.720
PI 33 6.2 [4.3–8.6] 16 6.0 [3.5–9.6] 17 6.3 [3.7–10] 0.892
Single class 39 7.3 [5.2–9.9] 21 7.9 [5.0–11.9] 18 6.7 [4.0–10.4]  
Two classes 1 0.2 [0–1.1] 0 0 1 0.4 [0–2.2]  
Three classes 2 0.4 [0–1.5] 1 0.4 [0–2.6] 1 0.4 [0–2.2]  

MSM, men who have sex with men; NRTI, nucleoside reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI, protease inhibitors; single-, two-, or three-class resistance is defined as one or more TDR within one, two, or three antiretroviral drug classes, respectively.